To explore underlying molecular mechanisms of HRH1 in promoting progression of HNSCC, we initially employed a GSEA to compare gene profiles between patients with the top 5% highest (N = 26) or lowest 5% (N = 26) HRH1 expression levels in TCGA HNSCC cohort. This evidence concerns the gene HRH1 and head and neck squamous cell carcinoma.